Cargando…
DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway
DNA damage-induced apoptosis suppressor (DDIAS) promotes the progression of lung cancer and hepatocellular carcinoma through the regulation of multiple pathways. We screened a chemical library for anticancer agent(s) capable of inhibiting DDIAS transcription. DGG-100629 was found to suppress lung ca...
Autores principales: | Im, Joo-Young, Kim, Bo-Kyung, Yoon, Sung-Hoon, Cho, Byoung Chul, Baek, Yu Mi, Kang, Mi-Jung, Kim, Nayeon, Gong, Young-Dae, Won, Misun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102629/ https://www.ncbi.nlm.nih.gov/pubmed/33859351 http://dx.doi.org/10.1038/s12276-021-00601-2 |
Ejemplares similares
-
DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells
por: Im, Joo-Young, et al.
Publicado: (2020) -
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
por: Im, Joo-Young, et al.
Publicado: (2023) -
Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells
por: Won, Kyoung-Jae, et al.
Publicado: (2017) -
Data on the transcriptional regulation of DNA damage induced apoptosis suppressor (DDIAS) by ERK5/MEF2B pathway in lung cancer cells
por: Im, Joo-Young, et al.
Publicado: (2016) -
NFATc1 regulates the transcription of DNA damage-induced apoptosis suppressor
por: Im, Joo-Young, et al.
Publicado: (2015)